Table 6.
Author (yr) | N | Baseline | p16 IHC (%) | F/U time (mo.) | Progress CIN2+ | Results |
---|---|---|---|---|---|---|
Razmpoosh (2014)(15) | 64 | CIN1 | 27.4 | > 6 | 25.00% | p = 0.002 |
Liao (2014)(16) | 171 | Normal | 42.7 | 24 | 10.70% | RR 8.25 (1.02-66.62) |
CIN1 | ||||||
Pacchiarotti (2014)(17) | 124 | Normal | 50.8 | 24 | 10.30% | RR 5.20 (0.60-47.50) |
CIN1 | ||||||
Sagasta (2016)(18) | 416 | HPV | 11.3 | 28 | 22.40% | HR 1.6 (0.9–2.6) |
CIN1 | ||||||
This study | 108 | HPV | 22.2 | 22 | 16.70% | HR 5.29 (1.18-23.76) |
CIN1 |